-
Amorim JH, Alves RP, Boscardin SB, Ferreira LC, 2014: The dengue virus non-structural 1 protein: risks and benefits[J]. Virus Res, 181, 53-60. doi: 10.1016/j.virusres.2014.01.001
-
Atkins JF, Loughran G, Bhatt PR, Firth AE, Baranov PV, 2016: Ribosomal frameshifting and transcriptional slippage: from genetic steganography and cryptography to adventitious use[J]. Nucl Acids Res, 44, 7007-7078. doi: 10.1093/nar/gkw530
-
Balinsky CA, Schmeisser H, Wells AI, Ganesan S, Jin T, Singh K, Zoon KC, 2017: IRAV (FLJ11286), an interferon-stimulated gene with antiviral activity against dengue virus, interacts with MOV10[J]. J Virol, 91, e01606-16. doi: 10.1128/jvi.01606-16
-
Brakier-Gingras L, Charbonneau J, Butcher SE, 2012: Targeting frameshifting in the human immunodeficiency virus[J]. Expert Opin Ther Targets, 16, 249-258. doi: 10.1517/14728222.2012.665879
-
Caliskan N, Peske F, Rodnina MV, 2015: Changed in translation: mRNA recoding by -1 programmed ribosomal frameshifting[J]. Trends Biochem Sci, 40, 265-274. doi: 10.1016/j.tibs.2015.03.006
-
Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS, 2011: Estimated global incidence of Japanese encephalitis: a systematic review[J]. Bull World Health Organ, 89, 766-774. doi: 10.2471/BLT.10.085233
-
Chambers TJ, Weir RC, Grakoui A, Mccourt DW, Bazan JF, Fletterick RJ, Rice CM, 1990: Evidence that the N-terminal domain of nonstructural protein Ns3 from yellow-fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein[J]. Proc Natl Acad Sci USA, 87, 8898-8902. doi: 10.1073/pnas.87.22.8898
-
Chambers TJ, Droll DA, Jiang X, Wold WS, Nickells JA, 2007: JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease[J]. Virology, 366, 51-61. doi: 10.1016/j.virol.2007.04.016
-
Chen CJ, Kuo MD, Chien LJ, Hsu SL, Wang YM, Lin JH, 1997: RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA[J]. J Virol, 71, 3466-3473. doi: 10.1128/jvi.71.5.3466-3473.1997
-
Dulude D, Berchiche YA, Gendron K, Brakier-Gingras L, Heveker N, 2006: Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1[J]. Virology, 345, 127-136. doi: 10.1016/j.virol.2005.08.048
-
Firth AE, Atkins JF, 2009: A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1' may derive from ribosomal frameshifting[J]. Virol J, 6, 14-. doi: 10.1186/1743-422X-6-14
-
Gregersen LH, Schueler M, Munschauer M, Mastrobuoni G, Chen W, Kempa S, Dieterich C, Landthaler M, 2014: MOV10 Is a 5' to 3' RNA helicase contributing to UPF1 mRNA target degradation by translocation along 3' UTRs[J]. Mol Cell, 54, 573-585. doi: 10.1016/j.molcel.2014.03.017
-
Hartmann R, Justesen J, Sarkar SN, Sen GC, Yee VC, 2003: Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase[J]. Mol Cell, 12, 1173-1185. doi: 10.1016/S1097-2765(03)00433-7
-
Hung M, Patel P, Davis S, Green SR, 1998: Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication[J]. J Virol, 72, 4819-4824. doi: 10.1128/JVI.72.6.4819-4824.1998
-
Impoinvil DE, Baylis M, Solomon T, 2013: Japanese encephalitis: on the one health agenda[J]. Curr Top Microbiol Immunol, 365, 205-247. doi: 10.1007/82_2012_243
-
Karacostas V, Wolffe EJ, Nagashima K, Gonda MA, Moss B, 1993: Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles[J]. Virology, 193, 661-671. doi: 10.1006/viro.1993.1174
-
Kinast V, Plociennikowska A, Anggakusuma BT, Todt D, Brown RJP, Boldanova T, Zhang Y, Bruggemann Y, Friesland M, Engelmann M, Vieyres G, Broering R, Vondran FWR, Heim MH, Sitek B, Bartenschlager R, Pietschmann T, Steinmann E, 2020: C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle[J]. J Hepatol, 73, 549-558. doi: 10.1016/j.jhep.2020.03.047
-
Li HT, Clum S, You SH, Ebner KE, Padmanabhan R, 1999: The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids[J]. J Virol, 73, 3108-3116. doi: 10.1128/JVI.73.4.3108-3116.1999
-
Lopez AL, Aldaba JG, Roque VG Jr, Tandoc AO Ⅲ, Sy AK, Espino FE, DeQuiroz-Castro M, Jee Y, Ducusin MJ, Fox KK, 2015: Epidemiology of Japanese encephalitis in the Philippines: a systematic review[J]. PLoS Negl Trop Dis, 9, e0003630-. doi: 10.1371/journal.pntd.0003630
-
Makki MS, Heinzel T, Englert C, 2008: TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels[J]. Nucl Acids Res, 36, 4067-4078. doi: 10.1093/nar/gkn356
-
Melian EB, Hinzman E, Nagasaki T, Firth AE, Wills NM, Nouwens AS, Blitvich BJ, Leung J, Funk A, Atkins JF, Hall R, Khromykh AA, 2010: NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness[J]. J Virol, 84, 1641-1647. doi: 10.1128/JVI.01979-09
-
Mizushima N, Yoshimori T, Levine B, 2010: Methods in mammalian autophagy research[J]. Cell, 140, 313-326. doi: 10.1016/j.cell.2010.01.028
-
Morita K, Nabeshima T, Buerano C, 2015: Japanese encephalitis[J]. Revue Scientifique Et Technique (Int Office Epizoot), 34, 441-452.
-
Muller DA, Young PR, 2013: The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker[J]. Antivir Res, 98, 192-208. doi: 10.1016/j.antiviral.2013.03.008
-
Perelygin AA, Zharkikh AA, Scherbik SV, Brinton MA, 2006: The mammalian 2'-5' oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla[J]. J Mol Evol, 63, 562-576. doi: 10.1007/s00239-006-0073-3
-
Preugschat F, Lenches EM, Strauss JH, 1991: Flavivirus enzyme-substrate interactions studied with chimeric proteinases—identification of an intragenic locus important for substrate recognition[J]. J Virol, 65, 4749-4758. doi: 10.1128/jvi.65.9.4749-4758.1991
-
Rastogi M, Sharma N, Singh SK, 2016: Flavivirus NS1: a multifaceted enigmatic viral protein[J]. Virol J, 13, 131-. doi: 10.1186/s12985-016-0590-7
-
Rodriguez W, Srivastav K, Muller M, 2019: C19ORF66 Broadly escapes virus-induced endonuclease cleavage and restricts Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 93, e00373-19.
-
Saftig P, Klumperman J, 2009: Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function[J]. Nat Rev Mol Cell Biol, 10, 623-635. doi: 10.1038/nrm2745
-
Schmeisser H, Mejido J, Balinsky CA, Morrow AN, Clark CR, Zhao T, Zoon KC, 2010: Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene[J]. J Virol, 84, 10671-10680. doi: 10.1128/JVI.00818-10
-
Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM, 2011: A diverse range of gene products are effectors of the type I interferon antiviral response[J]. Nature, 472, 481-485. doi: 10.1038/nature09907
-
Shehu-Xhilaga M, Crowe SM, Mak J, 2001: Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity[J]. J Virol, 75, 1834-1841. doi: 10.1128/JVI.75.4.1834-1841.2001
-
Singh MK, Scott TF, LaFramboise WA, Hu FZ, Post JC, Ehrlich GD, 2007: Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy[J]. J Neurol Sci, 258, 52-59. doi: 10.1016/j.jns.2007.02.034
-
Solomon T, Vaughn DW, 2002: Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections[J]. Jpn Encephalitis West Nile Viruses, 267, 171-194. doi: 10.1007/978-3-642-59403-8_9
-
Sun J, Yu Y, Deubel V, 2012: Japanese encephalitis virus NS1' protein depends on pseudoknot secondary structure and is cleaved by caspase during virus infection and cell apoptosis[J]. Microbes Infect, 14, 930-940. doi: 10.1016/j.micinf.2012.03.007
-
Suzuki Y, Chin WX, Han Q, Ichiyama K, Lee CH, Eyo ZW, Ebina H, Takahashi H, Takahashi C, Tan BH, Hishiki T, Ohba K, Matsuyama T, Koyanagi Y, Tan YJ, Sawasaki T, Chu JJ, Vasudevan SG, Sano K, Yamamoto N, 2016: Characterization of RyDEN (C19orf66) as an interferon-stimulated cellular inhibitor against dengue virus replication[J]. PLoS Pathog, 12, e1005357-. doi: 10.1371/journal.ppat.1005357
-
Taylor MW, Tsukahara T, McClintick JN, Edenberg HJ, Kwo P, 2008: Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment[J]. J Transl Med, 6, 66-. doi: 10.1186/1479-5876-6-66
-
Unni SK, Ruzek D, Chhatbar C, Mishra R, Johri MK, Singh SK, 2011: Japanese encephalitis virus: from genome to infectome[J]. Microbes Infect, 13, 312-321. doi: 10.1016/j.micinf.2011.01.002
-
Utama A, Shimizu H, Morikawa S, Hasebe F, Morita K, Igarashi A, Hatsu M, Takamizawa K, Miyamura T, 2000: Identification and characterization of the RNA helicase activity of Japanese encephalitis virus NS3 protein[J]. FEBS Lett, 465, 74-78. doi: 10.1016/S0014-5793(99)01705-6
-
van den Hurk AF, Ritchie SA, Mackenzie JS, 2009: Ecology and geographical expansion of Japanese encephalitis virus[J]. Annu Rev Entomol, 54, 17-35. doi: 10.1146/annurev.ento.54.110807.090510
-
Wang J, Li X, Gu J, Fan Y, Zhao P, Cao R, Chen P, 2015: The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection[J]. Infect Genet Evol, 36, 116-125. doi: 10.1016/j.meegid.2015.09.013
-
Wang X, Xuan Y, Han Y, Ding X, Ye K, Yang F, Gao P, Goff SP, Gao G, 2019: Regulation of HIV-1 Gag-Pol expression by shiftless, an inhibitor of programmed -1 ribosomal frameshifting[J]. Cell, 176, 625-635.e14. doi: 10.1016/j.cell.2018.12.030
-
Wu Y, Yang X, Yao Z, Dong X, Zhang D, Hu Y, Zhang S, Lin J, Chen J, An S, Ye H, Zhang S, Qiu Z, He Z, Huang M, Wei G, Zhu X, 2020: C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3[J]. PLoS Negl Trop Dis, 14, e0008083-. doi: 10.1371/journal.pntd.0008083
-
Ye Q, Li XF, Zhao H, Li SH, Deng YQ, Cao RY, Song KY, Wang HJ, Hua RH, Yu YX, Zhou X, Qin ED, Qin CF, 2012: A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation[J]. J Gen Virol, 93, 1959-1964. doi: 10.1099/vir.0.043844-0
-
Young LB, Melian EB, Khromykh AA, 2013: NS1' colocalizes with NS1 and can substitute for NS1 in West Nile virus replication[J]. J Virol, 87, 9384-9390. doi: 10.1128/JVI.01101-13
-
Yun SI, Song BH, Polejaeva IA, Davies CJ, White KL, Lee YM, 2016: Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo[J]. J Gen Virol, 97, 2575-2591. doi: 10.1099/jgv.0.000574
-
Zheng S, Zhu D, Lian X, Liu WT, Cao RB, Chen PY, 2016: Porcine 2', 5'-oligoadenylate synthetases inhibit Japanese encephalitis virus replication in vitro[J]. J Med Virol, 88, 760-768. doi: 10.1002/jmv.24397
-
Zhou D, Li Q, Jia F, Zhang L, Wan S, Li Y, Song Y, Chen H, Cao S, Ye J, 2020: The Japanese encephalitis virus NS1' protein inhibits type I IFN production by targeting MAVS[J]. J Immunol, 204, 1287-1298. doi: 10.4049/jimmunol.1900946
-
Zimmerer JM, Lesinski GB, Ruppert AS, Radmacher MD, Noble C, Kendra K, Walker MJ, Carson WE 3rd, 2008: Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-αlpha[J]. Clin Cancer Res, 14, 5900-5906. doi: 10.1158/1078-0432.CCR-08-0846